PHAR vs QURE: Side-by-Side Comparison
Compare Pharming Group N.V. (PHAR) and uniQure N.V. (QURE) side by side: market cap USD 965.83M vs USD 2.64B. Financials, growth and model signals on Bullrun.
| Metric | PHAR | QURE |
|---|---|---|
| Company | Pharming Group N.V. | uniQure N.V. |
| Country / Exchange | Netherlands · NASDAQ | Netherlands · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 965.83M | USD 2.64B |
| P/E ratio | 79.9 | — |
| Dividend yield | — | — |
| Valuation model | 37.6% overvalued | — |
| Revenue (latest FY) | — | USD 16.10M |
| Revenue growth YoY | — | -40.6% |
| Net income | — | USD -199.00M |
| Gross margin | — | 89.5% |
| Diluted EPS | — | -3.46 |